#GLP1 #MetabolicHealth #WeightManagement #Nutraceuticals #BotanicalExtracts #GreenCoffeeBean #ChlorogenicAcid #NaturalAlternatives #ObesityManagement #SupplementScience #DrugDiscontinuation #SustainableWeightLoss #EvidenceBasedNutrition #ProductDevelopment #FormulationScience #PreventiveNutrition #MetabolicSupport #FunctionalIngredients #ClinicalNutrition #PostGLP1 #WeightRegain #NutraceuticalInnovation #PharmaTransition #HerbalMedicine #WellnessScience To view or add a comment, sign in New Clinical on High-Dose Safety Profile for Ashwagandha Root Extract A recent prospective, non-comparative clinical trial published in Frontiers in Nutrition evaluated the safety and tolerability of a standardized Ashwagandha (Withania somnifera) root extract (KSM-66 Ashwagandha) at a high dose of 2,000 mg/day over a 12-week period

Independent testing across the sector has repeatedly turned up material that is underdosed, mislabelled, or substituted with a cheaper or different compound than the label claims and fabricated or unverifiable Certificates of Analysis are a well-known problem
If compounding were as bad as purported....then the courts would have struck down this method of medicine preparation years ago
Surgeons rely on established protocols of pain management, swelling control, structured rehabilitation, and progressive loading
Many patients come to my office in Tucson having already tried to get Wegovy through their insurance, only to be denied or told they need to meet criteria that seem almost intentionally difficult to satisfy